Effect of Preoperative Dutasteride on Bleeding Related to Transurethral Resection of Prostate in Patients with Benign Prostatic Hyperplasia

ISSN Print: 2327-5081
ISSN Online: 2327-509X
www.scirp.net/journal/jbm
E-mail: [email protected]

Citations

"Effect of Preoperative Dutasteride on Bleeding Related to Transurethral Resection of Prostate in Patients with Benign Prostatic Hyperplasia"
written by Md. Mostafiger Rahman, Fatema-Tuj Johura, Md. Amanur Rasul, Abul Kalam Mohammed Musa Bhuiyan, Mohammad Ibrahim Ali, Md. Sazzad Hossain, Md. Kamrul Islam, A. K. M. Shahidur Rahman, Fahad Al Shatil Ashrafee,
published by Journal of Biosciences and Medicines, Vol.7 No.5, 2019

has been cited by the following article(s):

[1]	The Effect Of 4-Weeks Dutasteride Use On Perioperative Blood Loss In Patients Undergoing Transurethral Resection Of Prostate
	Pakistan Journal of …, 2023

[2]	A multicenter retrospective study of transurethral prostate split for benign prostate hyperplasia
	Translational …, 2022

[3]	Transparent Hose Has the Advantages of Reducing Surgical Trauma and Complications in the Treatment of Benign Prostatic Hyperplasia Patients with …
	Indian Journal of Pharmaceutical …, 2021

[4]	Transparent Hose Has the Advantages of Reducing Surgical Trauma and Complications in the Treatment of Benign Prostatic Hyperplasia Patients with Bladder …
	2021

[5]	The role of preoperative dutasteride in reducing bleeding during transurethral resection of the prostate: A systematic review and meta-analysis of randomized …
	2021

[6]	Effectiveness of short Pre-operative treatment with Dutasteride on per-operative blood loss in TURP: A Randomized Controlled Trial
	2021

[1]	Comparison of Intraoperative Blood Loss in Monopolar Transurethral Resection of the Prostate With and Without Two Weeks of Preoperative Dutasteride Cureus, 2025 DOI:10.7759/cureus.80493

[2]	Comparison of Intraoperative Blood Loss in Patients With Benign Prostatic Hyperplasia Undergoing Bipolar Transurethral Resection of the Prostate With and Without Preoperative Oral Finasteride Cureus, 2025 DOI:10.7759/cureus.90920